Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12>>>
32 Items
Title  Creator  Group name  Publishing year 
The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases Khellaf et al. EquipeMY 2022-09-08
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) Delhorme et al. EquipePM 2022-01
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors Palassin et al. EquipeMY 2021
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27) Samalin et al. EquipeMY May 15, 2020
Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept Sgarbura et al. EquipePM 2020
[Tumor banks and complex data management: Current and future challenges] Hofman et al. EquipeMY Feb 25, 2019
[Biomarker, what is the pathologist's role?] Bibeau EquipeMY Jun 2019
[Augmented pathology, future or present ?] Badoual and Bibeau EquipeMY Mar 14, 2019
Multicenter evaluation of a novel ROS1 immunohistochemistry assay (SP384) for detection of ROS1 rearrangements in a large cohort of lung adenocarcinoma patients Hofman et al. EquipeMY Apr 15, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes Bonnefoi et al. EquipeMY Mar 22, 2019
Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival Quénet et al. EquipeMY Nov 16, 2018
Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status Cohen et al. EquipeMY Nov 15, 2018
[The MSI status: An almost ideal marker!] Bibeau EquipeMY Dec 2017
[Predictive biomarkers of efficacy of checkpoint blockade inhibitors in cancer treatment] Duruisseaux et al. EquipeMY Feb 2017
[Immune response and digestive cancers: Prognostic and therapeutic implications] Bibeau et al. EquipeMY Feb 2017
[FREGAT: French clinico-biological database dedicated to esogastric cancers] Renaud et al. EquipeMY Dec 2017
[A special issue dedicated to immuno-oncology] Bibeau and Badoual EquipeMY Feb 2017
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer Prieur et al. EquipeMY Sep 01, 2017
Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) Gérard et al. EquipeMY Apr 2017
Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function Guiu et al. EquipeMY Aug 2017
Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options Duffour et al. EquipeMY 06 2016
Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas Boissière-Michot et al. EquipeMY Aug 2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers Ferrari et al. EquipeMY 07 13, 2016
[Peritoneal tumor pathology - case no. 8: desmoplastic small round cell tumor] Bibeau EquipeMY Aug 2015
[Peritoneal tumor pathology - case no. 6: major histologic colloid response of colorectal peritoneal carcinomatosis after induction treatment] Bibeau EquipeMY Aug 2015
12>>>
32 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés